The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence
dc.contributor.author | Buchynskyi, Mykhailo | |
dc.contributor.author | Kamyshna, Iryna | |
dc.contributor.author | Oksenych, Valentyn | |
dc.contributor.author | Zavidniuk, Nataliia | |
dc.contributor.author | Kamyshnyi, Aleksandr | |
dc.date.accessioned | 2023-10-31T15:15:08Z | |
dc.date.available | 2023-10-31T15:15:08Z | |
dc.date.created | 2023-06-16T12:36:03Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Viruses. 2023, 15 (5), . | en_US |
dc.identifier.issn | 1999-4915 | |
dc.identifier.uri | https://hdl.handle.net/11250/3099827 | |
dc.language.iso | eng | en_US |
dc.publisher | MDPI | en_US |
dc.rights | Navngivelse 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.no | * |
dc.title | The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence | en_US |
dc.title.alternative | The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence | en_US |
dc.type | Journal article | en_US |
dc.type | Peer reviewed | en_US |
dc.description.version | publishedVersion | en_US |
dc.source.pagenumber | 0 | en_US |
dc.source.volume | 15 | en_US |
dc.source.journal | Viruses | en_US |
dc.source.issue | 5 | en_US |
dc.identifier.doi | 10.3390/v15051072 | |
dc.identifier.cristin | 2155260 | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 |